Article successfully added.

CyFlow™ GRAP2 Purified

CyFlow™ GRAP2 Purified
Alternative Name: GADS
Antibody: Yes
Antigen: GRAP2
Application: Flow cytometry, Immunoprecipitation, Western blot
Clonality: monoclonal
Clone: UW40
Field of Interest: Adaptor proteins
Format/Fluorochrome: Purified
Isotype: IgG2a
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human
Product number: CE576626

For Research Use Only

$120.00 USD*

Price excludes any applicable taxes plus shipping costs

Description Documentation TDS & SDS
Description
Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 mL... more
Close menu
CyFlow™ GRAP2 Purified
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1 mL
ImmunogenGST fusion human GRAP2/GADS protein
Background InformationGRAP2; Grb2-related adaptor protein 2 or GADS; Grb2-related adaptor downstream of Shc, is a cytoplasmic adaptor protein containing N- and C-terminal SH3 domains flanking a central SH2 domain and a proline/glutamine-rich region. It is expressed predominantly in lymphoid tissue and hematopoietic cells, particularly in T cells. GRAP2 (GADS) plays a pivotal role during the early events of T cell signal transduction by recruiting the adaptor protein SLP-76 and its associated molecules, such as Vav, Nck, Itk, and ADAP, to the transmembrane adaptor protein LAT. GRAP2 (GADS) also binds several other signaling proteins, namely Gab2, HPK1 (hematopoietic progenitor kinase 1), and Cbl. Unlike similar adaptor protein Grb2, GRAP2 (GADS) shows higher selectivity when binding to the particular phosphorylated tyrosines of LAT adaptor.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Yankee TM, Draves KE, Ewings MK, Clark EA, Graves JD: CD95/Fas induces cleavage of the GrpL/Gads adaptor and desensitization of antigen receptor signaling. Proc Natl Acad Sci USA. 2001 Jun 5; 98(12):6789‑93. < PMID: 11391000 > | Cho S, Velikovsky CA, Swaminathan CP, Houtman JC, Samelson LE, Mariuzza RA: Structural basis for differential recognition of tyrosine‑phosphorylated sites inthe linker for activation of T cells (LAT) by the adaptor Gads. EMBO J. 2004 Apr 7; 23(7):1441‑51. < PMID: 15029250 > | Yankee TM, Yun TJ, Draves KE, Ganesh K, Bevan MJ, Murali-Krishna K, Clark EA: The Gads (GrpL) adaptor protein regulates T cell homeostasis. J Immunol. 2004 Aug 1; 173(3):1711‑20. < PMID: 15265900 > | Watanabe R, Harada Y, Takeda K, Takahashi J, Ohnuki K, Ogawa S, Ohgai D, Kaibara N, Koiwai O, Tanabe K, Toma H, Sugamura K, Abe R: Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28‑mediated costimulation. J Immunol. 2006 Jul 15; 177(2):1085‑91. < PMID: 16818765 > | Moran O, Roessle MW, Mariuzza RA, Dimasi N: Structural features of the full‑length adaptor protein GADS in solution determined using small‑angle X‑ray scattering. Biophys J. 2008 Mar 1; 94(5):1766‑72. < PMID: 17993503 > | Dalheimer SL, Zeng L, Draves KE, Hassaballa A, Jiwa NN, Parrish TD, Clark EA, Yankee TM: Gads‑deficient thymocytes are blocked at the transitional single positive CD4+stage. Eur J Immunol. 2009 May; 39(5):1395‑404. < PMID: 19337995 >

TDS & SDS
Close menu

Technical Data Sheet

Safety Data Sheet